SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Simonian NA, Coyle JT 1996 Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol 36: 83106.
  • 2
    Ilich JZ, Brownbill RA, Tamborini L 2003 Bone and nutrition in elderly women: Protein, energy, and calcium as main determinants of bone mineral density. Eur J Clin Nutr 57: 554565.
  • 3
    Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM 2004 Nutritional associations with bone loss during the menopausal transition: Evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 79: 155165.
  • 4
    Melhus H, Michaelsson K, Holmberg L, Wolk A, Ljunghall S 1999 Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 14: 129135.
  • 5
    Maggio D, Barabani M, Pierandrei M, Polidori MC, Catani M, Mecocci P, Senin U, Pacifici R, Cherubini A 2003 Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J Clin Endocrinol Metab 88: 15231527.
  • 6
    Weber P 1999 The role of vitamins in the prevention of osteoporosis-a brief status report. Int J Vitam Nutr Res 69: 194197.
  • 7
    Hall SL, Greendale GA 1998 The relation of dietary vitamin C intake to bone mineral density: Results from the PEPI study. Calcif Tissue Int 63: 183189.
  • 8
    Patrick L 2003 Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity. Altern Med Rev 8: 106128.
  • 9
    Kurokouchi K, Kambe F, Yasukawa K, Izumi R, Ishiguro N, Iwata H, Seo H 1998 TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 13: 12901299.
  • 10
    Yang S, Madyastha P, Bingel S, Ries W, Key L 2001 A new superoxide-generating oxidase in murine osteoclasts. J Biol Chem 276: 54525458.
  • 11
    Sontakke AN, Tare RS 2002 A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin Chim Acta 318: 145148.
  • 12
    Pacifici R 1996 Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11: 10431051.
  • 13
    Horowitz MC, Xi Y, Wilson K, Kacena MA 2001 Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands. Cytokine Growth Factor Rev 12: 918.
  • 14
    Nanes MS 2003 Tumor necrosis factor-alpha: Molecular and cellular mechanisms in skeletal pathology. Gene 321: 115.
  • 15
    Kitajima I, Soejima Y, Takasaki I, Beppu H, Tokioka T, Maruyama I 1996 Ceramide-induced nuclear translocation of NF-kappa B is a potential mediator of the apoptotic response to TNF-alpha in murine clonal osteoblasts. Bone 19: 263270.
  • 16
    Hill PA, Tumber A, Meikle MC 1997 Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology 138: 38493858.
  • 17
    Jilka RL, Weinstein RS, Bellido T, Parfitt AM, Manolagas SC 1998 Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines. J Bone Miner Res 13: 793802.
  • 18
    Hock JM, Krishnan V, Onyia JE, Bidwell JP, Milas J, Stanislaus D 2001 Osteoblast apoptosis and bone turnover. J Bone Miner Res 16: 975984.
  • 19
    Ashkenazi A, Dixit VM 1999 Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11: 255260.
  • 20
    Baud V, Karin M 2001 Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372377.
  • 21
    Micheau O, Tschopp J 2003 Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181190.
  • 22
    Littlejohn AF, Tucker SJ, Mohamed AA, McKay S, Helms MJ, Vandenabeele P, MacEwan DJ 2003 Modulation by caspases of tumor necrosis factor-stimulated c-Jun N-terminal kinase activation but not nuclear factor-kappaB signaling. Biochem Pharmacol 65: 9199.
  • 23
    Thorburn A 2004 Death receptor-induced cell killing. Cell Signal 16: 139144.
  • 24
    Ginn-Pease ME, Whisler RL 1998 Redox signals and NF-kappaB activation in T cells. Free Radic Biol Med 25: 346361.
  • 25
    Higuchi M, Proske RJ, Yeh ET 1998 Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 17: 25152524.
  • 26
    Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ 1998 The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 18: 63536364.
  • 27
    Moini H, Packer L, Saris NE 2002 Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 182: 8490.
  • 28
    Romero FJ, Ordonez I, Arduini A, Cadenas E 1992 The reactivity of thiols and disulfides with different redox states of myoglobin. Redox and addition reactions and formation of thiyl radical intermediates. J Biol Chem 267: 16801688.
  • 29
    Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GJ, Henriksen EJ 1996 The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45: 10241029.
  • 30
    Fuchs J, Schofer H, Milbradt R, Freisleben HJ, Buhl R, Siems W, Grune T 1993 Studies on lipoate effects on blood redox state in human immunodeficiency virus infected patients. Arzneimittelforschung 43: 13591362.
  • 31
    Packer L, Tritschler HJ, Wessel K 1997 Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 22: 359378.
  • 32
    Kim GS, Hong JS, Kim SW, Koh JM, An CS, Choi JY, Cheng SL 2003 Leptin induces apoptosis via ERK/cPLA2/cytochrome c pathway in human bone marrow stromal cells. J Biol Chem 278: 2192021929.
  • 33
    Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV 1994 Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134: 277286.
  • 34
    Kim CH, Cheng SL, Kim GS 1997 Lack of autocrine effects of IL-6 on human bone marrow stromal osteoprogenitor cells. Endocr Res 23: 181190.
  • 35
    Donahue HJ, Li Z, Zhou Z, Yellowley CE 2000 Differentiation of human fetal osteoblastic cells and gap junctional intercellular communication. Am J Physiol Cell Physiol 278: C315C322.
  • 36
    Zhang L, Rubinow DR, Xaing G, Li BS, Chang YH, Maric D, Barker JL, Ma W 2001 Estrogen protects against beta-amyloid-induced neurotoxicity in rat hippocampal neurons by activation of Akt. Neuroreport 12: 19191923.
  • 37
    Li J, Li W, Su J, Liu W, Altura BT, Altura BM 2003 Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: Possible relation to neurodegenerative diseases and strokes. Brain Res Bull 62: 101106.
  • 38
    Orie NN, Zidek W, Tepel M 2000 Increased intracellular generation of reactive oxygen species in mononuclear leukocytes from patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 108: 175180.
  • 39
    Schreiber S, Nikolaus S, Hampe J 1998 Activation of nuclear factor kappa B inflammatory bowel disease. Gut 42: 477484.
  • 40
    Chen K, Vita JA, Berk BC, Keaney JF Jr 2001 c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J Biol Chem 276: 1604516050.
  • 41
    Aoki H, Kang PM, Hampe J, Yoshimura K, Noma T, Matsuzaki M, Izumo S 2002 Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 277: 1024410250.
  • 42
    Janssen-Heininger YM, Poynter ME, Baeuerle PA 2000 Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic Biol Med 28: 13171327.
  • 43
    Li N, Karin M 1999 Is NF-kappaB the sensor of oxidative stress? FASEB J 13: 11371143.
  • 44
    Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R 1995 Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136: 30543061.
  • 45
    Kimble RB, Bain S, Pacifici R 1997 The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12: 935941.
  • 46
    Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R 2001 Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98: 1396013965.
  • 47
    Chen Q, Chai YC, Mazumder S, Jiang C, Macklis RM, Chisolm GM, Almasan A 2003 The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activation, and mitochondrial dysfunction. Cell Death Differ 10: 323334.
  • 48
    Simon HU, Haj-Yehia A, Levi-Schaffer F 2000 Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5: 415418.
  • 49
    Stridh H, Kimland M, Jones DP, Orrenius S, Hampton MB 1998 Cytochrome c release and caspase activation in hydrogen peroxide- and tributyltin-induced apoptosis. FEBS Lett 429: 351355.
  • 50
    Goossens V, Grooten J, De Vos K, Fiers W 1995 Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92: 81158119.
  • 51
    Goossens V, De Vos K, Vercammen D, Steemans M, Vancompernolle K, Fiers W, Vandenabeele P, Grooten J 1999 Redox regulation of TNF signaling. Biofactors 10: 145156.
  • 52
    Siemankowski LM, Morreale J, Briehl MM 1999 Antioxidant defenses in the TNF-treated MCF-7 cells: Selective increase in MnSOD. Free Radic Biol Med 26: 919924.
  • 53
    Chandel NS, Schumacker PT, Arch RH 2001 Reactive oxygen species are downstream products of TRAF-mediated signal transduction. J Biol Chem 276: 4272842736.
  • 54
    Qin ZH, Wang Y, Kikly KK, Sapp E, Kegel KB, Aronin N, DiFiglia M 2001 Pro-caspase-8 is predominantly localized in mitochondria and released into cytoplasm upon apoptotic stimulation. J Biol Chem 276: 80798086.
  • 55
    Morikawa T, Yasuno R, Wada H 2001 Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett 498: 1621.
  • 56
    Sen CK, Roy S, Han D, Packer L 1997 Regulation of cellular thiols in human lymphocytes by alpha-lipoic acid: A flow cytometric analysis. Free Radic Biol Med 22: 12411257.
  • 57
    McCarty MF 2001 Versatile cytoprotective activity of lipoic acid may reflect its ability to activate signalling intermediates that trigger the heat-shock and phase II responses. Med Hypotheses 57: 313317.
  • 58
    Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ 2003 A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112: 915923.
  • 59
    Schwabe RF, Uchinami H, Qian T, Bennett BL, Lemasters JJ, Brenner DA 2004 Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes. FASEB J 18: 720722.
  • 60
    Pantano C, Shrivastava P, McElhinney B, Janssen-Heininger Y 2003 Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase. J Biol Chem 278: 4409144096.
  • 61
    Davis RJ 2000 Signal transduction by the JNK group of MAP kinases. Cell 103: 239252.
  • 62
    Sabapathy K, Jochum W, Hochedlinger K, Chang L, Karin M, Wagner EF 1999 Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 89: 115124.
  • 63
    Hess P, Pihan G, Sawyers CL, Flavell RA, Davis RJ 2002 Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat Genet 32: 201205.
  • 64
    Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ 2003 JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell 11: 14791489.
  • 65
    Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, Davis RJ 2000 Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870874.
  • 66
    Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D, Davis RJ 2002 The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 22: 49294942.
  • 67
    Hayakawa M, Miyashita H, Sakamoto I, Kitagawa M, Tanaka H, Yasuda H, Karin M, Kikugawa K 2003 Evidence that reactive oxygen species do not mediate NF-kappaB activation. EMBO J 22: 33563366.
  • 68
    Lin KI, DiDonato JA, Hoffmann A, Hardwick JM, Ratan RR 1998 Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis. J Cell Biol 141: 14791487.
  • 69
    Davis JN, Kucuk O, Djuric Z, Sarkar FH 2001 Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Radic Biol Med 30: 12931302.